Athira Pharma
ATHA
ATHA
104 hedge funds and large institutions have $354M invested in Athira Pharma in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 35 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.05% less ownership
Funds ownership: 7.03% → 6.98% (-0.05%)
26% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 35
Holders
104
Holding in Top 10
1
Calls
$41.5M
Puts
$19.2M
Top Buyers
| 1 | +$9.36M | |
| 2 | +$3.14M | |
| 3 | +$2.67M | |
| 4 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
+$2.53M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.11M |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$3.39M | |
| 3 | -$2.29M | |
| 4 |
PVI
Pura Vida Investments
New York
|
-$1.82M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$1.52M |